Rapid Dose Therapeutics Advances Cannabinoid Studies for QuickStrip Drug Delivery Platform
Oral thin film cannabinoid delivery is an emerging technology addressing challenges in cannabis medicine. This delivery method offers faster onset and more precise dosing compared to traditional edibles. QuickStrip's platform exemplifies innovation in…
IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial
The Phase 2 CALMA trial expands clinical sites for cannabinoid-based therapy Alzheimer agitation, offering new hope for managing difficult symptoms. This cannabinoid-based therapy Alzheimer agitation approach targets neuroinflammation and behavioral…
DOJ Suggests ‘Frail and Elderly Grandmother’ Could Face Armed Federal Agents
The DOJ grandmothers medical marijuana enforcement risks highlight federal law conflicts with state medical cannabis programs. Even frail elderly patients could face armed federal agents. This legal tension affects cannabis and firearms rights under the…
Study Challenges Negative Cannabis Stereotypes, Claiming Link to Brain Benefits
The cannabis brain volume study analyzed data from over 26,000 adults aged 40-77, revealing larger brain volumes in moderate cannabis users. This study highlights cannabis cognitive effects, showing better performance in memory and processing speed.…